Expression of E-cadherin in drug resistant human breast cancer cells and their sensitivity to lymphokine-activated lymphocytes action

Experimental Oncology

Volumn 31, Issue 4, 2009, Pages 242-245

  Berezhnaya, N M ^a   Belova, O B ^a   Vinnichuk, Yu D ^a   Tarutinov, V I ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Drug resistance; E cadherin; LAK; Malignant breast tumors; Proliferative activity

Indexed keywords

CELL NUCLEUS ANTIGEN; LECTIN RECEPTOR; UVOMORULIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER CELL; CANCER RESISTANCE; CELL PROLIFERATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; EXPLANT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; LYMPHOKINE ACTIVATED KILLER CELL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS;

BREAST NEOPLASMS; CADHERINS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, LYMPHOKINE-ACTIVATED; RECEPTORS, MITOGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 75149151464     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Berezhnaya NM, Kovalchuk EV, Vinnichuk YD, et al. Experimental immunotherapy of mice with transplated MC-rhabdomiocarcoma resistant to doxorubicin. Exp Oncol 2004; 26: 63-7.
2. Berezhnaya NM, Vinnichuk YD, Konovalenko VF, et al. The sensitivity of chemoresistant human tumor explants to lysis by activated and nonactivated autologous lymphocytes: a pilot study. Exp Oncol 2005; 27: 303-7.
3. Belova OB, Vinnichuk UD, Shlakhovenko VA, et al. Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicin-sensitive transplantable rhabdomyosarcoma. Exp Oncol 2007; 29: 272-6.
4. Vinnichuk YD, Belova OB, Kirnasovskaya EA, et al. The features of growth of the benign and malignant breast tumor in diffusion chambers. Oncology 2009; 11: 174-9.
5. Berezhnaya NM, Chekhun VF. System of interleukins and cancer. Kyiv: DIA, 2000; 224 p (In Russian).
6. 7 (CD103) expression identifies a highly active, tonsil-resident effector-memory CTL population. J Immunol 2005; 17: 4355-62.
7. Taneyhill LA, Coles EG, Bronner-Fraser M. Snail2 directly represses cadherin6B during epithelial-to-mesenchymal transitions of the neural crest. Development 2007; 134: 1481-90.
8. Wheelock M, Shintani Y, Maeda M, et al. Cadherin switching. J Cell Sci 2008; 121: 727-35.
9. Feltes CM, Kudo A, Blaschuk O, et al. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res 2002; 62: 6688-97.
10. Moore R, Champeval D, Denat L, et al. Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation. Oncogene 2004; 23: 6726-35.
11. Shpyleva SI, Yurchenko OV, Volkova KD, et al. Value of tumor biomarkers with the different drug resistance phenotype for current of disease at breast cancer patients. Oncology 2007; 9: 110-4.
12. Chekhun VF, Lukyanova NY, Kovalchuk O, et al. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol Cancer Ther 2007; 6: 1089-98.
13. Zhao H, Liang Y, Xu Z, et al. N-glycosylation affects the adhesive function of E-Cadherin through modifying the composition of adherens junctions (AJs) in human breast carcinoma cell line MDA-MB-435. J Cell Biochem 2008; 104: 162-75.
14. Howard EW, Leung SC, Yuen HF, et al. Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer. Clin Exp Metastasis 2008; 25: 497-508.
15. Wang L, Li Z, Wang C, et al. E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression. Arch Biochem Biophys 2009; 481: 116-22.
16. Criswell TL, Arteaga CL. Modulation of NFκB Activity and E-cadherin by the Type III transforming growth factor β receptor regulates cell growth and motility. J Biol Chem 2007; 282: 32491-500.
17. Qian X, Karpova T, Sheppard AM, et al. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 2004; 23 (8): 1739-48.
18. Perrais M, Chen X, Perez-Moreno M, et al. E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell 2007; 18: 2013-25.
19. Hazan RB, Phillips GR, Qiao RF, et al. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000; 148: 779-90.
20. Cheshuk VE, Berezhna NM, Kovalchuk OV, Kozlenko OV. The means for determination of indications for chemotherapy of breast cancer. Patent of Ukraine No 50595A from 15.10.2002 (In Ukrainian).
21. Samsonova EA, Maximova NA, Urmancheeva AF, et al. Expression of receptors of estrogens, progesterone and Her2 oncoprotein as an index of clinical course and outcome of endometryoid adenocarcinoma of corpus uteri (immunohistochemical study). Voprosi Oncologii 2004; 50: 196-201 (In Russain).
22. Brembeck FH, Rosário M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 2006; 16: 51-9.
23. Hollmann CA, Kittrell FS, Medina D, Butel JS. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Oncogene 2001; 20: 7645-57.
24. Du C, Jaggi M, Zhang C, et al. Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin. Cancer Res 2009; 69: 1117-24.
25. Chua HL, Bhat-Nakshatri P, Clare SE, et al. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 2007; 26: 711-24.
26. Szakács G, Gottesman MM. Comparing solid tumors with cell lines: implications for identifying drug resistance genes in cancer. Mol Interv 2004; 4: 323-5.
27. Green SK, Karlsson MC, Ravetch JV, et al. Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer. Cancer Res 2002; 62: 6891-900.
28. Green SK, Francia G, Isidoro C, et al. Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro. Mol Cancer Ther 2004; 3: 149-59.